News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
256,849 Results
Type
Article (13746)
Company Profile (255)
Press Release (242848)
Section
Business (79188)
Career Advice (147)
Deals (13169)
Drug Delivery (28)
Drug Development (50191)
Employer Resources (31)
FDA (5640)
Job Trends (5103)
News (143681)
Policy (10011)
Tag
Academia (901)
Africa (145)
Allergies (30)
Alliances (21408)
Alzheimer's disease (689)
Antibody-drug conjugate (ADC) (32)
Approvals (5615)
Arizona (39)
Artificial intelligence (35)
Asia (16664)
Australia (2789)
Bankruptcy (96)
Best Places to Work (4377)
Biotechnology (215)
Breast cancer (30)
C2C Services and Suppliers (10603)
California (1333)
Canada (522)
Cancer (348)
Career advice (128)
CAR-T (35)
Cell therapy (106)
China (99)
Clinical research (39182)
Collaboration (107)
Colorado (44)
Compensation (43)
Connecticut (47)
COVID-19 (987)
Cystic fibrosis (61)
Data (320)
Diabetes (45)
Diagnostics (1162)
Earnings (28370)
Europe (35780)
Events (45900)
Executive appointments (105)
FDA (5789)
Florida (137)
Funding (112)
Gene therapy (87)
GLP-1 (265)
Government (1055)
Healthcare (6510)
Hotbed/Location (184111)
Illinois (83)
Indiana (45)
Infectious disease (1000)
Inflammatory bowel disease (80)
IPO (7139)
Job creations (856)
Job search strategy (124)
Kansas (52)
Layoffs (177)
Legal (1369)
Lung cancer (77)
Manufacturing (36)
Maryland (202)
Massachusetts (1080)
Medical device (2518)
Medtech (2519)
Mergers & acquisitions (6048)
Metabolic disorders (146)
Michigan (38)
Minnesota (66)
Neuroscience (822)
New Jersey (357)
New York (422)
NextGen Class of 2024 (1978)
Non-profit (837)
North Carolina (335)
Northern California (583)
Obesity (83)
Ohio (64)
Opinion (87)
Parkinson's disease (43)
Patents (36)
Pennsylvania (294)
People (24736)
Pharmaceutical (41)
Phase I (13740)
Phase II (18212)
Phase III (11598)
Pipeline (89)
Postmarket research (845)
Preclinical (5782)
Press Release (30)
Radiopharmaceuticals (199)
Rare diseases (115)
Real estate (1406)
Regulatory (8061)
Research institute (928)
South America (207)
Southern California (550)
Startups (1963)
Texas (124)
United States (5028)
Vaccines (141)
Washington State (158)
Weight loss (60)
Date
Today (84)
Last 7 days (362)
Last 30 days (1531)
Last 365 days (21302)
2024 (15576)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11739)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
256,849 Results for "lisata therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that management will participate in the following events in June.
May 28, 2024
·
2 min read
Pharm Country
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that management will participate in the following events in May.
May 8, 2024
·
3 min read
Pharm Country
Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer
Lisata Therapeutics, Inc. today announced that it has reached agreement with the European Medicines Agency (the “EMA”) on a Paediatric Investigation Plan (“PIP”) for Lisata’s lead investigational product, certepetide (formerly LSTA1), in pancreatic cancer.
May 20, 2024
·
7 min read
Drug Development
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, announced the successful completion of patient enrollment for the pancreatic cancer cohort in the Phase 1b/2a CENDIFOX trial.
June 13, 2024
·
7 min read
Pharm Country
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
Lisata Therapeutics, Inc. today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will participate in the following events in April.
April 3, 2024
·
2 min read
Press Releases
Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events
September 9, 2024
·
1 min read
Business
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, provided a business update and reported financial results for the three months ended March 31, 2024.
May 9, 2024
·
13 min read
Press Releases
Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
September 5, 2024
·
7 min read
Press Releases
Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial
September 17, 2024
·
6 min read
Pharm Country
Lisata Therapeutics to Present at BIO CEO & Investor Conference
Lisata Therapeutics, Inc. today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present at the BIO CEO & Investor Conference being held on February 26-27, 2024 at the New York Marriott Marquis in New York City.
February 20, 2024
·
1 min read
1 of 25,685
Next
